Literature DB >> 24568455

PLGA-based nanoparticles as cancer drug delivery systems.

Fatemeh Sadat Tabatabaei Mirakabad1, Kazem Nejati-Koshki, Abolfazl Akbarzadeh, Mohammad Rahmati Yamchi, Mortaza Milani, Nosratollah Zarghami, Vahideh Zeighamian, Amirbahman Rahimzadeh, Somayeh Alimohammadi, Younes Hanifehpour, Sang Woo Joo.   

Abstract

Poly (lactic-co-glycolic acid) (PLGA) is one of the most effective biodegradable polymeric nanoparticles (NPs). It has been approved by the US FDA to use in drug delivery systems due to controlled and sustained- release properties, low toxicity, and biocompatibility with tissue and cells. In the present review, the structure and properties of PLGA copolymers synthesized by ring-opening polymerization of DL-lactide and glicolide were characterized using 1H nuclear magnetic resonance spectroscopy, gel permeation chromatography, Fourier transform infrared spectroscopy and differential scanning calorimetry. Methods of preparation and characterization, various surface modifications, encapsulation of diverse anticancer drugs, active or passive tumor targeting and different release mechanisms of PLGA nanoparticles are discussed. Increasing experience in the application of PLGA nanoparticles has provided a promising future for use of these nanoparticles in cancer treatment, with high efficacy and few side effects.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24568455     DOI: 10.7314/apjcp.2014.15.2.517

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  68 in total

1.  Improved Treatment of Pancreatic Cancer With Drug Delivery Nanoparticles Loaded With a Novel AKT/PDK1 Inhibitor.

Authors:  Joseph E Kobes; Iman Daryaei; Christine M Howison; Jordan G Bontrager; Rachael W Sirianni; Emmanuelle J Meuillet; Mark D Pagel
Journal:  Pancreas       Date:  2016-09       Impact factor: 3.327

Review 2.  Insight into nanoparticle cellular uptake and intracellular targeting.

Authors:  Basit Yameen; Won Il Choi; Cristian Vilos; Archana Swami; Jinjun Shi; Omid C Farokhzad
Journal:  J Control Release       Date:  2014-06-28       Impact factor: 9.776

Review 3.  Systemic delivery to central nervous system by engineered PLGA nanoparticles.

Authors:  Qiang Cai; Long Wang; Gang Deng; Junhui Liu; Qianxue Chen; Zhibiao Chen
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

Review 4.  Engineering Biomaterial-Drug Conjugates for Local and Sustained Chemotherapeutic Delivery.

Authors:  Jeannine M Coburn; David L Kaplan
Journal:  Bioconjug Chem       Date:  2015-03-02       Impact factor: 4.774

5.  Configuration-dependent Presentation of Multivalent IL-15:IL-15Rα Enhances the Antigen-specific T Cell Response and Anti-tumor Immunity.

Authors:  Enping Hong; Ilana M Usiskin; Cristina Bergamaschi; Douglas J Hanlon; Richard L Edelson; Sune Justesen; George N Pavlakis; Richard A Flavell; Tarek M Fahmy
Journal:  J Biol Chem       Date:  2015-12-30       Impact factor: 5.157

Review 6.  Magnetic nanoformulations for prostate cancer.

Authors:  Pallabita Chowdhury; Allison M Roberts; Sheema Khan; Bilal B Hafeez; Subhash C Chauhan; Meena Jaggi; Murali M Yallapu
Journal:  Drug Discov Today       Date:  2017-05-16       Impact factor: 7.851

7.  Nanoparticle-Based Topical Ophthalmic Gel Formulation for Sustained Release of Hydrocortisone Butyrate.

Authors:  Xiaoyan Yang; Hoang M Trinh; Vibhuti Agrahari; Ye Sheng; Dhananjay Pal; Ashim K Mitra
Journal:  AAPS PharmSciTech       Date:  2015-06-18       Impact factor: 3.246

Review 8.  PLA micro- and nano-particles.

Authors:  Byung Kook Lee; Yeonhee Yun; Kinam Park
Journal:  Adv Drug Deliv Rev       Date:  2016-06-01       Impact factor: 15.470

9.  Extended release microparticle-in-gel formulation of octreotide: Effect of polymer type on acylation of peptide during in vitro release.

Authors:  Ravi D Vaishya; Abhirup Mandal; Sulabh Patel; Ashim K Mitra
Journal:  Int J Pharm       Date:  2015-11-10       Impact factor: 5.875

10.  Dual-Targeting Nanoparticles for In Vivo Delivery of Suicide Genes to Chemotherapy-Resistant Ovarian Cancer Cells.

Authors:  Emiliano Cocco; Yang Deng; Erik M Shapiro; Ileana Bortolomai; Salvatore Lopez; Ken Lin; Stefania Bellone; Jiajia Cui; Gulden Menderes; Jonathan D Black; Carlton L Schwab; Elena Bonazzoli; Fan Yang; Federica Predolini; Luca Zammataro; Gary Altwerger; Christopher de Haydu; Mitchell Clark; Julio Alvarenga; Elena Ratner; Masoud Azodi; Dan-Arin Silasi; Peter E Schwartz; Babak Litkouhi; W Mark Saltzman; Alessandro D Santin
Journal:  Mol Cancer Ther       Date:  2016-12-12       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.